JPH06510020A
(ja)
*
|
1991-03-29 |
1994-11-10 |
ユニバーシティ・オブ・フロリダ |
混成リン酸エステル誘導体を経た標的への薬剤供給
|
DE4142570A1
(de)
*
|
1991-12-21 |
1993-06-24 |
Basf Ag |
Glykolaldehyd- und milchsaeurederivate, deren herstellung und verwendung
|
GB9205917D0
(en)
*
|
1992-03-18 |
1992-04-29 |
Smithkline Beecham Plc |
Pharmaceuticals
|
US5849905A
(en)
*
|
1994-11-23 |
1998-12-15 |
Centre National De La Recherche Scientifique |
Biologically active phosphotriester-type nucleosides and methods for preparing same
|
FR2691463A1
(fr)
*
|
1992-05-25 |
1993-11-26 |
Centre Nat Rech Scient |
Dérivés nucléotidiques, leur préparation et leur application en thérapeutique.
|
US6020482A
(en)
*
|
1992-05-25 |
2000-02-01 |
Gosselin; Gilles |
Phosphotriester type biologically active compounds
|
FR2692265B1
(fr)
*
|
1992-05-25 |
1996-11-08 |
Centre Nat Rech Scient |
Composes biologiquement actifs de type phosphotriesters.
|
US5770725A
(en)
*
|
1992-05-25 |
1998-06-23 |
Gosselin; Gilles |
Phosphotriester type biologically active compounds
|
US6057305A
(en)
*
|
1992-08-05 |
2000-05-02 |
Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic |
Antiretroviral enantiomeric nucleotide analogs
|
US5817647A
(en)
*
|
1993-04-01 |
1998-10-06 |
Merrell Pharmaceuticals Inc. |
Unsaturated acetylene phosphonate derivatives of purines
|
US5955591A
(en)
*
|
1993-05-12 |
1999-09-21 |
Imbach; Jean-Louis |
Phosphotriester oligonucleotides, amidites and method of preparation
|
CA2126601A1
(fr)
*
|
1993-06-29 |
1994-12-30 |
Mitsubishi Chemical Corporation |
Derives d'ester phosphonate de nucleotide
|
JP4086314B2
(ja)
*
|
1993-09-17 |
2008-05-14 |
ギリアード サイエンシーズ, インコーポレイテッド |
ヌクレオチドアナログ
|
US5656745A
(en)
*
|
1993-09-17 |
1997-08-12 |
Gilead Sciences, Inc. |
Nucleotide analogs
|
KR100386685B1
(ko)
*
|
1993-09-17 |
2003-12-31 |
길리애드 사이언시즈, 인코포레이티드 |
뉴클레오타이드동족체류
|
US5798340A
(en)
|
1993-09-17 |
1998-08-25 |
Gilead Sciences, Inc. |
Nucleotide analogs
|
US5627185A
(en)
*
|
1994-11-23 |
1997-05-06 |
Gosselin; Gilles |
Acyclovir derivatives as antiviral agents
|
US5977061A
(en)
*
|
1995-04-21 |
1999-11-02 |
Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic |
N6 - substituted nucleotide analagues and their use
|
US5717095A
(en)
*
|
1995-12-29 |
1998-02-10 |
Gilead Sciences, Inc. |
Nucleotide analogs
|
NZ325704A
(en)
*
|
1995-12-29 |
2000-02-28 |
Gilead Sciences Inc |
Nucleotide analogs
|
US6093816A
(en)
|
1996-06-27 |
2000-07-25 |
Isis Pharmaceuticals, Inc. |
Cationic lipids
|
WO1998004569A1
(fr)
*
|
1996-07-26 |
1998-02-05 |
Gilead Sciences, Inc. |
Analogues de nucleotides
|
US5922695A
(en)
*
|
1996-07-26 |
1999-07-13 |
Gilead Sciences, Inc. |
Antiviral phosphonomethyoxy nucleotide analogs having increased oral bioavarilability
|
AU713374B2
(en)
*
|
1996-07-26 |
1999-12-02 |
Gilead Sciences, Inc. |
Nucleotide analogs
|
ZA986614B
(en)
|
1997-07-25 |
1999-01-27 |
Gilead Sciences |
Nucleotide analog composition
|
DE69809749T2
(de)
*
|
1997-07-25 |
2003-09-11 |
Gilead Sciences, Inc. |
Nukleotid-analoge zusammensetzung
|
CN1763057B
(zh)
*
|
1997-07-25 |
2012-10-17 |
吉尔利德科学股份有限公司 |
核苷酸类似物组合物
|
US5935946A
(en)
*
|
1997-07-25 |
1999-08-10 |
Gilead Sciences, Inc. |
Nucleotide analog composition and synthesis method
|
US6312662B1
(en)
|
1998-03-06 |
2001-11-06 |
Metabasis Therapeutics, Inc. |
Prodrugs phosphorus-containing compounds
|
ES2401070T3
(es)
*
|
1998-03-06 |
2013-04-16 |
Metabasis Therapeutics, Inc. |
Nuevos profármacos para compuestos que contienen fósforo
|
US6444652B1
(en)
*
|
1998-08-10 |
2002-09-03 |
Novirio Pharmaceuticals Limited |
β-L-2'-deoxy-nucleosides for the treatment of hepatitis B
|
KR100634342B1
(ko)
*
|
1998-08-10 |
2006-10-16 |
이데닉스(케이만)리미티드 |
B형 간염의 치료용 β-L-2'-데옥시-뉴클레오시드
|
US6635278B1
(en)
|
1998-12-15 |
2003-10-21 |
Gilead Sciences, Inc. |
Pharmaceutical formulations
|
TWI230618B
(en)
*
|
1998-12-15 |
2005-04-11 |
Gilead Sciences Inc |
Pharmaceutical compositions of 9-[2-[[bis[(pivaloyloxy)methyl]phosphono]methoxy]ethyl]adenine and tablets or capsules containing the same
|
US7205404B1
(en)
|
1999-03-05 |
2007-04-17 |
Metabasis Therapeutics, Inc. |
Phosphorus-containing prodrugs
|
MXPA01008937A
(es)
*
|
1999-03-05 |
2004-04-05 |
Metabasis Therapeutics Inc |
Nuevos profarmacos que contienen fosforo.
|
AU7361400A
(en)
*
|
1999-09-08 |
2001-04-10 |
Metabasis Therapeutics, Inc. |
Prodrugs for liver specific drug delivery
|
EP1233770B1
(fr)
*
|
1999-12-03 |
2008-02-13 |
The Regents of The University of California at San Diego |
Composes de phosphonate
|
IL150062A0
(en)
*
|
1999-12-17 |
2002-12-01 |
Ariad Pharma Inc |
Proton pump inhibitors
|
AU2001245575A1
(en)
*
|
2000-03-09 |
2001-09-17 |
Videoshare, Inc. |
Sharing a streaming video
|
HRP20160074B1
(hr)
*
|
2000-07-21 |
2021-09-03 |
Gilead Sciences, Inc. |
Prolijekovi koji su fosfonatni analozi nukleotida i metode njihovog odabira te njihova priprava
|
MY141789A
(en)
*
|
2001-01-19 |
2010-06-30 |
Lg Chem Investment Ltd |
Novel acyclic nucleoside phosphonate derivatives, salts thereof and process for the preparation of the same.
|
CN1329404C
(zh)
|
2001-06-29 |
2007-08-01 |
捷克科学院有机化学和生物化学研究所 |
具有抗病毒活性的6-2'-(膦酰基甲氧基)烷氧基嘧啶衍生物
|
AU2003299492B2
(en)
|
2002-05-13 |
2010-06-10 |
Metabasis Therapeutics, Inc. |
Cyclic prodrugs of PMEA one of its analogues
|
CA2485597C
(fr)
*
|
2002-05-13 |
2013-07-02 |
Metabasis Therapeutics, Inc. |
Procede destine a la preparation de promedicaments cycliques de la pmea et de la pmpa
|
EP1546164A4
(fr)
*
|
2002-09-26 |
2006-06-07 |
Lg Life Sciences Ltd |
Trans-isomeres (+) de derives de nucleoside ( 1-phosphonomethoxy-2-alkylcyclopropyl)methyle, processus de preparation de stereo-isomeres de ceux-ci et utilisation d'agents antiviraux a base ceux-ci
|
WO2004035577A2
(fr)
*
|
2002-10-16 |
2004-04-29 |
Gilead Sciences, Inc. |
Composes tricycliques pre-organises inhibiteurs d'integrase
|
CA2503730C
(fr)
|
2002-10-31 |
2011-10-18 |
Metabasis Therapeutics, Inc. |
Promedicaments de cytarabine monophosphate
|
KR101101962B1
(ko)
*
|
2002-11-12 |
2012-01-02 |
티안진 디실리 인베스트먼트 홀딩 그룹, 리미티드 |
새로운 결정 형태를 가진 아데포비어 디피복실의 제조 방법
|
WO2004064846A1
(fr)
*
|
2003-01-14 |
2004-08-05 |
Gilead Sciences, Inc. |
Compositions et methodes de polytherapie antivirale
|
JP5069463B2
(ja)
|
2003-04-25 |
2012-11-07 |
ギリアード サイエンシーズ, インコーポレイテッド |
抗ウイルス性ホスホネート類似物
|
SI1644389T1
(sl)
|
2003-06-16 |
2011-06-30 |
Acad Of Science Czech Republic |
Pirimidinske spojine s fosfonatnimi skupinami kot antivirusni nukleotidni analogi
|
US20050065171A1
(en)
*
|
2003-06-25 |
2005-03-24 |
Shakespeare William C. |
Substituted purine derivatives
|
NZ544988A
(en)
*
|
2003-07-30 |
2009-11-27 |
Gilead Sciences Inc |
Nucleobase phosphonate analogs for antiviral treatment
|
AU2004274493A1
(en)
*
|
2003-09-19 |
2005-03-31 |
Gilead Sciences, Inc. |
Aza-quinolinol phosphonate integrase inhibitor compounds
|
AU2004293013B2
(en)
*
|
2003-11-19 |
2011-04-28 |
Metabasis Therapeutics, Inc. |
Novel phosphorus-containing thyromimetics
|
ES2350983T3
(es)
*
|
2003-12-30 |
2011-01-28 |
Gilead Sciences, Inc. |
Fosfonatos, monofosfonamidatos, bisfosfonamidatos para el tratamiento de enfermedades víricas.
|
AU2005206511A1
(en)
*
|
2004-01-12 |
2005-08-04 |
Gilead Sciences, Inc. |
Pyrimidyl phosphonate antiviral compounds and methods of use
|
US20080153783A1
(en)
*
|
2004-01-12 |
2008-06-26 |
Gilead Sciences, Inc. |
Pyrimidyl Phosphonate Antiviral Compounds and Methods of Use
|
WO2005090370A1
(fr)
|
2004-02-05 |
2005-09-29 |
The Regents Of The University Of California |
Agents pharmacologiquement actifs contenant des phosphonates esterifies, et leurs procedes d'utilisation
|
EP1715873A1
(fr)
*
|
2004-02-17 |
2006-11-02 |
LG Life Sciences Ltd. |
Derives de nucleoside phosphonate utiles dans le traitement d'infections vih
|
PT1742642E
(pt)
*
|
2004-04-14 |
2009-01-23 |
Gilead Sciences Inc |
Análogos de fosfonato de compostos inibidores da integrase do hiv
|
AU2005254940A1
(en)
|
2004-06-08 |
2005-12-29 |
Metabasis Therapeutics, Inc. |
Lewis acid mediated synthesis of cyclic esters
|
CN100338080C
(zh)
*
|
2004-06-16 |
2007-09-19 |
山东中科泰斗化学有限公司 |
9-[2-(膦羧基甲氧基)乙基]腺嘌呤双环醇酯及其制备方法
|
UA93354C2
(ru)
|
2004-07-09 |
2011-02-10 |
Гилиад Сайенсиз, Инк. |
Местный противовирусный препарат
|
EP2316839B1
(fr)
*
|
2004-07-16 |
2014-03-12 |
Gilead Sciences, Inc. |
Composés hétérocycliques antiviraux avec des groupes phosphonates
|
BRPI0512690A
(pt)
|
2004-07-27 |
2007-11-27 |
Gilead Sciences Inc |
análogos de fosfonato de compostos inibidores de hiv
|
EP1865967A4
(fr)
*
|
2005-04-08 |
2011-02-09 |
Chimerix Inc |
Composes, compositions et methodes de traitement d'infections virales et autres troubles medicaux
|
WO2006110655A2
(fr)
|
2005-04-08 |
2006-10-19 |
Chimerix, Inc. |
Composes, compositions et methodes de traitement des infections a poxvirus
|
TW200716632A
(en)
*
|
2005-05-16 |
2007-05-01 |
Gilead Sciences Inc |
Integrase inhibitor compounds
|
CA2606499C
(fr)
|
2005-05-26 |
2017-06-13 |
Metabasis Therapeutics, Inc. |
Composes thyromimetiques utilises pour traiter les maladies hepatiques graisseuses
|
RU2007148927A
(ru)
*
|
2005-05-26 |
2009-07-10 |
Метабэйзис Терапьютикс, Инк. (Us) |
Новые тиреомиметики, содержащие фосфиновую кислоту
|
TWI471145B
(zh)
|
2005-06-13 |
2015-02-01 |
Bristol Myers Squibb & Gilead Sciences Llc |
單一式藥學劑量型
|
TWI375560B
(en)
|
2005-06-13 |
2012-11-01 |
Gilead Sciences Inc |
Composition comprising dry granulated emtricitabine and tenofovir df and method for making the same
|
CN100526315C
(zh)
|
2005-06-16 |
2009-08-12 |
浙江医药股份有限公司新昌制药厂 |
N2-喹啉或异喹啉取代的嘌呤衍生物及其制备方法和其用途
|
TW200738742A
(en)
*
|
2005-07-14 |
2007-10-16 |
Gilead Sciences Inc |
Antiviral compounds
|
TWI389908B
(zh)
*
|
2005-07-14 |
2013-03-21 |
Gilead Sciences Inc |
抗病毒化合物類
|
WO2007015824A2
(fr)
|
2005-07-25 |
2007-02-08 |
Intermune, Inc. |
Nouveaux inhibiteurs macrocycliques de la multiplication du virus de l’hépatite c
|
JP2009502964A
(ja)
*
|
2005-07-27 |
2009-01-29 |
ギリアード サイエンシーズ, インコーポレイテッド |
Hivを阻害するための抗ウイルス性ホスホン酸結合体
|
NZ572367A
(en)
*
|
2006-05-16 |
2011-09-30 |
Gilead Sciences Inc |
Fused cyclic compounds as integrase inhibitors
|
WO2008005542A2
(fr)
|
2006-07-07 |
2008-01-10 |
Gilead Sciences, Inc., |
Composés antiviraux à base de phosphinate
|
ES2388969T3
(es)
*
|
2006-07-07 |
2012-10-22 |
Gilead Sciences, Inc. |
Compuestos antivirales de fosfinato
|
JP5372751B2
(ja)
*
|
2006-07-21 |
2013-12-18 |
ギリアード サイエンシーズ, インコーポレイテッド |
Aza−ペプチドプロテアーゼ阻害剤
|
US7723380B2
(en)
*
|
2006-07-21 |
2010-05-25 |
Gilead Sciences, Inc. |
Antiviral protease inhibitors
|
FR2908133B1
(fr)
*
|
2006-11-08 |
2012-12-14 |
Centre Nat Rech Scient |
Nouveaux analogues de nucleotides comme molecules precurseurs d'antiviraux
|
CN101190927B
(zh)
*
|
2006-11-30 |
2012-04-18 |
天津天士力集团有限公司 |
9-[2-(膦酰甲氧)乙基]腺嘌呤单特戊酰氧甲酯的制备方法
|
WO2008154817A1
(fr)
|
2007-06-18 |
2008-12-24 |
Zhang, Zhongneng |
Thiazolyl-dihydropyrimidines à substitution bromo-phényle
|
ITMI20071594A1
(it)
*
|
2007-08-02 |
2009-02-03 |
Solmag Spa |
Forma cristallina monoidrata di adefovir dipivoxil
|
WO2009094191A2
(fr)
*
|
2008-01-25 |
2009-07-30 |
Chimerix, Inc. |
Méthodes de traitement d’infections virales
|
TWI444384B
(zh)
|
2008-02-20 |
2014-07-11 |
Gilead Sciences Inc |
核苷酸類似物及其在治療惡性腫瘤上的用途
|
US20110059921A1
(en)
*
|
2008-03-27 |
2011-03-10 |
Ektar Therapeutics |
Oligomer-Nitrogenous Base Conjugates
|
NZ588670A
(en)
|
2008-04-23 |
2012-08-31 |
Gilead Sciences Inc |
Carba-nucleoside analogs for antiviral treatment
|
TW201010692A
(en)
|
2008-06-19 |
2010-03-16 |
Public Univ Corp Nagoya City Univ |
Pharmaceutical composition for treatment or prevention of hbv infection
|
AU2009268681B2
(en)
|
2008-07-08 |
2014-10-02 |
Gilead Sciences, Inc. |
Salts of HIV inhibitor compounds
|
KR20100031045A
(ko)
*
|
2008-09-11 |
2010-03-19 |
씨제이제일제당 (주) |
아데포비어 디피복실의 정제방법
|
KR20100032803A
(ko)
|
2008-09-18 |
2010-03-26 |
씨제이제일제당 (주) |
아데포비어디피복실의 개선된 제조방법
|
KR20110075019A
(ko)
*
|
2008-10-15 |
2011-07-05 |
인터뮨, 인크. |
치료용 항바이러스성 펩티드
|
RU2485121C1
(ru)
|
2009-03-26 |
2013-06-20 |
Даевунг Фармасьютикал Ко., Лтд. |
Новые кристаллические формы адефовира дипивоксила и способы его получения
|
CN104211713B
(zh)
|
2009-05-13 |
2017-04-12 |
吉利德制药有限责任公司 |
抗病毒化合物
|
US8614200B2
(en)
|
2009-07-21 |
2013-12-24 |
Chimerix, Inc. |
Compounds, compositions and methods for treating ocular conditions
|
US7973013B2
(en)
|
2009-09-21 |
2011-07-05 |
Gilead Sciences, Inc. |
2'-fluoro substituted carba-nucleoside analogs for antiviral treatment
|
CA2773773C
(fr)
|
2009-09-21 |
2019-04-23 |
Gilead Sciences, Inc. |
Procedes et intermediaires pour preparer des analogues de carba-nucleoside 1'-substitues
|
EA201200525A1
(ru)
|
2009-09-21 |
2012-09-28 |
Гайлид Сайэнсиз, Инк. |
2'-фторзамещенные карба-нуклеозидные аналоги для противовирусного лечения
|
US20110082182A1
(en)
*
|
2009-10-01 |
2011-04-07 |
Intermune, Inc. |
Therapeutic antiviral peptides
|
EP2343056A1
(fr)
|
2009-12-30 |
2011-07-13 |
Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi |
Production d'une dispersion solide stable d'adefovir dipivoxil sous forme amorphe.
|
US9006218B2
(en)
|
2010-02-12 |
2015-04-14 |
Chimerix Inc. |
Nucleoside phosphonate salts
|
US20110223131A1
(en)
|
2010-02-24 |
2011-09-15 |
Gilead Sciences, Inc. |
Antiviral compounds
|
CA2797601A1
(fr)
|
2010-04-26 |
2011-11-10 |
Chimerix, Inc. |
Methodes de traitement d'infections retrovirales et regimes posologiques associes
|
CN101812090B
(zh)
*
|
2010-05-10 |
2013-08-14 |
浙江车头制药股份有限公司 |
一种阿德福韦单酯的制备方法
|
JP2013526581A
(ja)
|
2010-05-21 |
2013-06-24 |
ギリアード サイエンシーズ, インコーポレイテッド |
ヘテロ環式フラビウイルス科ウイルス阻害剤
|
PT2588450T
(pt)
|
2010-07-02 |
2017-08-03 |
Gilead Sciences Inc |
Derivados do ácido naft-2-ilacético para tratamento da sida
|
PE20130525A1
(es)
|
2010-07-02 |
2013-05-05 |
Gilead Sciences Inc |
Derivados de acido 2 quinolinil acetico como compuestos antivirales frente a vih
|
EP2805960A1
(fr)
|
2010-07-19 |
2014-11-26 |
Gilead Sciences, Inc. |
Procédés pour la préparation de promédicaments de phosphoramidate pur diastéromérique
|
CN101891767B
(zh)
*
|
2010-07-21 |
2012-05-23 |
浙江贝得药业有限公司 |
一种阿德福韦酯的制备方法
|
CA2804840C
(fr)
|
2010-07-22 |
2018-09-11 |
Gilead Sciences, Inc. |
Procedes et composes pour traiter des infections a virus paramyxoviridae
|
WO2012032541A1
(fr)
|
2010-09-06 |
2012-03-15 |
Matrix Laboratories Ltd |
Pseudopolymorphe d'adéfovir dipivoxil
|
TW201305185A
(zh)
|
2010-09-13 |
2013-02-01 |
Gilead Sciences Inc |
用於抗病毒治療之2’-氟取代之碳-核苷類似物
|
AU2011306066B2
(en)
|
2010-09-20 |
2015-01-29 |
Gilead Sciences, Inc. |
2' -fluoro substituted carba-nucleoside analogs for antiviral treatment
|
CN102093417B
(zh)
*
|
2010-11-15 |
2012-11-28 |
济南久创化学有限责任公司 |
一种可制备核苷膦酸类药物的化合物及其制备方法
|
PL2640719T3
(pl)
|
2010-11-17 |
2017-10-31 |
Gilead Pharmasset Llc |
Związki przeciwwirusowe
|
CA2818853A1
(fr)
|
2010-11-30 |
2012-06-07 |
Gilead Pharmasset Llc |
2'-spirocyclo-nucleosides destines a la therapie contre le virus de l'hepatite c et le virus de la dengue
|
CA2819548C
(fr)
|
2010-12-10 |
2019-04-09 |
Sigmapharm Laboratories, Llc |
Compositions tres stables d'analogues nucleotidiques actifs par voie orale ou de promedicaments sous forme d'analogues nucleotidiques actifs par voie orale
|
JP6043338B2
(ja)
|
2011-04-13 |
2016-12-14 |
ギリアード サイエンシーズ, インコーポレイテッド |
抗ウイルス治療用の1’−置換ピリミジンn−ヌクレオシド類似体
|
ES2615734T3
(es)
|
2011-04-21 |
2017-06-08 |
Gilead Sciences, Inc. |
Compuestos de benzotiazol y su uso farmacéutico
|
PT2729448E
(pt)
|
2011-07-06 |
2015-12-02 |
Gilead Sciences Inc |
Compostos para o tratamento de vih
|
WO2013025788A1
(fr)
|
2011-08-16 |
2013-02-21 |
Gilead Sciences, Inc. |
Hémifumarate de ténofovir alafénamide
|
KR20210043734A
(ko)
|
2011-11-16 |
2021-04-21 |
길리애드 파마셋 엘엘씨 |
항바이러스성 화합물로서의 축합된 이미다졸릴이미다졸
|
US9593137B2
(en)
|
2011-12-22 |
2017-03-14 |
Geron Corporation |
Guanine analogs as telomerase substrates and telomere length affectors
|
WO2013103738A1
(fr)
|
2012-01-04 |
2013-07-11 |
Gilead Sciences, Inc. |
Dérivés d'acide naphtalène acétique contre l'infection par le vih
|
WO2013103724A1
(fr)
|
2012-01-04 |
2013-07-11 |
Gilead Sciences, Inc. |
Dérivés d'acide 2-(tert-butoxy)-2-(7-méthylquinoléin-6-yl)acétique pour traiter le sida
|
JP6242378B2
(ja)
|
2012-03-13 |
2017-12-06 |
ギリアード サイエンシーズ, インコーポレイテッド |
抗ウイルス処置のための2’−置換カルバヌクレオシド類似体
|
RU2014115227A
(ru)
|
2012-04-20 |
2015-10-27 |
Джилид Сайэнс, Инк. |
Производные бензотиазол-6-ил уксусной кислоты и их примение для лечения вич-инфекции
|
WO2013167743A1
(fr)
|
2012-05-11 |
2013-11-14 |
Akron Molecules Gmbh |
Utilisation de composés pour le traitement de la douleur
|
US9079887B2
(en)
|
2012-05-16 |
2015-07-14 |
Gilead Sciences, Inc. |
Antiviral compounds
|
US20130309196A1
(en)
|
2012-05-16 |
2013-11-21 |
Gilead Sciences, Inc. |
Antiviral compounds
|
CN107312039B
(zh)
|
2012-08-30 |
2019-06-25 |
江苏豪森药业集团有限公司 |
一种替诺福韦前药的制备方法
|
CN102977146B
(zh)
*
|
2012-11-20 |
2016-04-20 |
广东肇庆星湖生物科技股份有限公司 |
一种腺嘌呤衍生物的合成方法
|
US9233974B2
(en)
|
2012-12-21 |
2016-01-12 |
Gilead Sciences, Inc. |
Antiviral compounds
|
JP6462659B2
(ja)
|
2013-03-15 |
2019-01-30 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
非環式ヌクレオシドホスホン酸ジエステル
|
CN110156838A
(zh)
*
|
2013-05-14 |
2019-08-23 |
北京美倍他药物研究有限公司 |
磷酸/膦酸衍生物及其医药用途
|
WO2015096697A1
(fr)
*
|
2013-12-23 |
2015-07-02 |
四川海思科制药有限公司 |
Dérivé de phosphonate de nucléoside acyclique et procédé de préparation et son utilisation en science médicale
|
EP3623364A1
(fr)
|
2014-02-13 |
2020-03-18 |
Ligand Pharmaceuticals, Inc. |
Composés de promédicaments et leurs utilisations
|
US10202353B2
(en)
|
2014-02-28 |
2019-02-12 |
Gilead Sciences, Inc. |
Therapeutic compounds
|
WO2015197006A1
(fr)
*
|
2014-06-25 |
2015-12-30 |
四川海思科制药有限公司 |
Composé thioester d'acide aminé substitué, et composition et application de celui-ci
|
CN106687118A
(zh)
|
2014-07-02 |
2017-05-17 |
配体药物公司 |
前药化合物及其用途
|
RS63250B1
(sr)
|
2014-09-15 |
2022-06-30 |
Univ California |
Nukleotidni analozi
|
TWI740546B
(zh)
|
2014-10-29 |
2021-09-21 |
美商基利科學股份有限公司 |
製備核糖苷的方法
|
GB201509431D0
(en)
*
|
2015-06-01 |
2015-07-15 |
Equigerminal Sa |
Antiviral composition
|
EP3350191B9
(fr)
|
2015-09-15 |
2021-12-22 |
The Regents of the University of California |
Analogues nucléotidiques
|
CN116617233A
(zh)
|
2015-09-16 |
2023-08-22 |
吉利德科学公司 |
治疗沙粒病毒科和冠状病毒科病毒感染的方法
|
CN105294762A
(zh)
*
|
2015-11-13 |
2016-02-03 |
中国药科大学 |
阿德福韦酯杂质的制备方法
|
CN106800573B
(zh)
*
|
2015-11-25 |
2020-03-10 |
四川海思科制药有限公司 |
一种核苷酸膦酸酯一水合物及其制备方法和在医药上的应用
|
KR102180740B1
(ko)
|
2016-08-19 |
2020-11-20 |
길리애드 사이언시즈, 인코포레이티드 |
Hiv 바이러스 감염의 예방적 또는 치유적 치료에 유용한 치료 화합물
|
WO2018039157A1
(fr)
*
|
2016-08-25 |
2018-03-01 |
Merck Sharp & Dohme Corp. |
Promédicaments antiviraux du ténofovir
|
EP3519409B1
(fr)
|
2016-09-28 |
2024-09-18 |
Gilead Sciences, Inc. |
Dérivés d'acide benzothiazol-6-yl-acétique et leur utilisation pour le traitement d'une infection par le vih
|
EP3541395A4
(fr)
|
2016-11-21 |
2020-07-01 |
Viking Therapeutics, Inc. |
Méthodes de traitement de glycogénose
|
EP3372227A1
(fr)
|
2017-03-06 |
2018-09-12 |
MH10 Spolka z ograniczona odpowiedzialnoscia |
Formulation de comprimé d'adéfovir dipivoxil
|
EP4331677A3
(fr)
|
2017-03-14 |
2024-05-29 |
Gilead Sciences, Inc. |
Procédés de traitement d'infections à coronavirus félin
|
EP3618929B1
(fr)
|
2017-05-01 |
2022-12-07 |
Gilead Sciences, Inc. |
Forme cristalline de (s) 2 éthylbutyl 2 (((s) (((2r,3s,4r,5r) 5 (4 aminopyrrolo[2,1-f][1,2,4]triazine-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2 yl)méthoxy)(phénoxy) phosphoryl)amino)propanoate
|
JP7168660B2
(ja)
|
2017-06-05 |
2022-11-09 |
バイキング・セラピューティクス・インコーポレイテッド |
線維症の処置のための組成物
|
CN111093627B
(zh)
|
2017-07-11 |
2024-03-08 |
吉利德科学公司 |
用于治疗病毒感染的包含rna聚合酶抑制剂和环糊精的组合物
|
EP3661937B1
(fr)
|
2017-08-01 |
2021-07-28 |
Gilead Sciences, Inc. |
Formes crystallines d'éthyl ((s)-((((2r,5r)-5-(6-amino-9h-purin-9-yl)-4-fluoro-2,5-dihydrofuran-2-yl)oxy)méthyl)(phénoxy)phosphoryl)-l-alaninate (gs-9131) pour le traitement des infections virales
|
AR112412A1
(es)
|
2017-08-17 |
2019-10-23 |
Gilead Sciences Inc |
Formas de sal de colina de un inhibidor de la cápside del vih
|
TW202024061A
(zh)
|
2017-08-17 |
2020-07-01 |
美商基利科學股份有限公司 |
Hiv蛋白質膜抑制劑之固體形式
|
EP3737676B1
(fr)
|
2018-01-09 |
2024-03-06 |
Ligand Pharmaceuticals, Inc. |
Composés acétal et leurs utilisations thérapeutiques
|
PL3752495T3
(pl)
|
2018-02-15 |
2024-01-15 |
Gilead Sciences, Inc. |
Pochodne pirydynowe i ich zastosowanie do leczenia infekcji hiv
|
KR20230145536A
(ko)
|
2018-02-16 |
2023-10-17 |
길리애드 사이언시즈, 인코포레이티드 |
레트로비리다에 바이러스 감염의 치료에 유용한 치료 화합물을 제조하기 위한 방법 및 중간체
|
EP3768690A4
(fr)
|
2018-03-22 |
2021-11-24 |
Viking Therapeutics, Inc. |
Formes cristallines et procédés de production de formes cristallines d'un composé
|
JP2021530523A
(ja)
|
2018-07-16 |
2021-11-11 |
ギリアード サイエンシーズ, インコーポレイテッド |
Hivの処置のためのカプシド阻害剤
|
WO2020117962A1
(fr)
|
2018-12-05 |
2020-06-11 |
Viking Therapeutics, Inc. |
Compositions pour le traitement de la fibrose et de l'inflammation
|
US20240139325A1
(en)
|
2019-10-17 |
2024-05-02 |
Ai-Biopharma |
Anti-viral and hepatic-targeted drugs
|
US11807625B2
(en)
|
2019-11-26 |
2023-11-07 |
Gilead Sciences, Inc. |
Capsid inhibitors for the prevention of HIV
|
AU2021214911A1
(en)
|
2020-01-27 |
2022-07-21 |
Gilead Sciences, Inc. |
Methods for treating SARS CoV-2 infections
|
TWI785528B
(zh)
|
2020-03-12 |
2022-12-01 |
美商基利科學股份有限公司 |
1’-氰基核苷之製備方法
|
US11701372B2
(en)
|
2020-04-06 |
2023-07-18 |
Gilead Sciences, Inc. |
Inhalation formulations of 1'-cyano substituted carba-nucleoside analogs
|
JP2023528810A
(ja)
|
2020-05-29 |
2023-07-06 |
ギリアード サイエンシーズ, インコーポレイテッド |
レムデシビル治療方法
|
CN115996928A
(zh)
|
2020-06-24 |
2023-04-21 |
吉利德科学公司 |
1’-氰基核苷类似物及其用途
|
AU2021296607B2
(en)
|
2020-06-25 |
2024-07-25 |
Gilead Sciences, Inc. |
Capsid inhibitors for the treatment of HIV
|
FI4204421T3
(fi)
|
2020-08-27 |
2024-06-25 |
Gilead Sciences Inc |
Koostumuksia ja menetelmiä virusinfektioiden hoitoon
|
AU2022279234A1
(en)
|
2021-05-21 |
2023-12-07 |
Gilead Sciences, Inc. |
Pentacyclic derivatives as zika virus inhibitors
|
CN113880883A
(zh)
*
|
2021-11-11 |
2022-01-04 |
奥锐特药业股份有限公司 |
核苷类磷酸酯前药的制备方法
|
KR20240117588A
(ko)
|
2021-12-03 |
2024-08-01 |
길리애드 사이언시즈, 인코포레이티드 |
Hiv 바이러스 감염 치료용 화합물
|
MX2024006396A
(es)
|
2021-12-03 |
2024-06-04 |
Gilead Sciences Inc |
Compuestos terapeuticos para la infeccion por el virus de inmunodeficiencia humana (vih).
|
WO2023167944A1
(fr)
|
2022-03-02 |
2023-09-07 |
Gilead Sciences, Inc. |
Composés et méthodes pour traiter des infections virales
|